Clinical Trials Directory

Trials / Completed

CompletedNCT02157688

Impact of Staphylococcus Aureus on Folliculitis Decalvans

Role of Staphylococcus Aureus on Folliculitis Decalvans. A Comparative Bacteriological Study.

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The folliculitis decalvans (FD) is an orphan disease , common in consultation specialized on scalp. This disease is currently not curable, responsible for significant for patients. The pathophysiology is poorly understood, Staphylococcus aureus (SA) appears to play a role, never previously studied, and the study will attempt to clarify it. Controversies in the literature on the pathophysiological hypotheses can be summed up as follows : FD is it an infectious folliculitis where SA (almost always found on the lesions plays a direct role possibly aided by a lack of local immune protection , or is it a pustular inflammatory unknown cause where the SA has no direct role but is a cofactor or a simple germ superinfection. Our study has plans to bring new evidence to help decide between these two opposite but not mutually exclusive concepts .

Conditions

Interventions

TypeNameDescription
OTHERno intervention : case control study

Timeline

Start date
2014-03-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-06-06
Last updated
2016-06-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02157688. Inclusion in this directory is not an endorsement.

Impact of Staphylococcus Aureus on Folliculitis Decalvans (NCT02157688) · Clinical Trials Directory